SCHEMBL1144216

SCHEMBL1144216

CCC(C)C(=O)OCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28883808 0.81 GABRR1 (0.39)
SCHEMBL9645822 0.80
SCHEMBL27523383 0.79
SCHEMBL248665 0.78 SOAT1 (0.39)
SCHEMBL5427965 0.78 ALDH1A1 (0.36)
SCHEMBL614185 0.78 SOAT1 (0.39)
SCHEMBL12987802 0.77
SCHEMBL12986226 0.77
SCHEMBL28071633 0.77
SCHEMBL4062275 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108129330-A A kind of cyclopropylamine continuous production system and production method 浙江沙星科技有限公司 2018-06-08 CN claimed
CN-104402782-B The synthetic method of 2-[(4-dodecyloxy phenyl) sulfuryl] butyric acid JIANGXI RENMING PHARMACEUTICAL CHEMICAL INDUSTRY CO., LTD. (CN) 2016-01-27 CN claimed
CN-104402782-A 2-[(4-dodecyloxy phenyl) sulfuryl] butyric acid synthetic method JIANGXI RENMING MEDICINE CHEMICAL CO LTD 2015-03-11 CN claimed
CN-108383798-A Phthalazinone derivatives prodrug or its pharmaceutically acceptable salt and its pharmaceutical composition and application 上海博邦医药科技有限公司 2018-08-10 CN disclosed
CN-108129330-A A kind of cyclopropylamine continuous production system and production method 浙江沙星科技有限公司 2018-06-08 CN disclosed
CN-107721850-A A kind of preparation method of cyclopropylamine intermediate γ chloro methyl butyrates 山东国邦药业股份有限公司 2018-02-23 CN disclosed
CN-107721850-A A kind of preparation method of cyclopropylamine intermediate γ chloro methyl butyrates 山东国邦药业股份有限公司 2018-02-23 CN disclosed
CN-107673973-A A kind of preparation method of cyclopropylamine intermediate cyclopropanecarboxylic acid methyl esters 山东国邦药业股份有限公司 2018-02-09 CN disclosed
CN-105906507-A Ester cyclopropanecarboxylate solvent-free synthesis method 成都化润药业有限公司 2016-08-31 CN disclosed
EP-3030233-A1 OXAZOLE OREXIN RECEPTOR ANTAGONISTS Merck Sharp & Dohme Corp. (US) 2016-06-15 EP disclosed
CN-205088160-U Gamma - chloro methyl butyrate's preparation facilities SHANDONG GUOBANG PHARMACEUTICAL CO LTD 2016-03-16 CN disclosed
EP-2185533-A2 QUERCETIN DERIVATIVES AS ANTI-CANCER AGENTS Dabur Pharma Limited (IN) 2010-05-19 EP disclosed
WO-2009019721-A2 QUERCETIN DERIVATIVES AS ANTI-CANCER AGENTS DABUR PHARMA LIMITED (IN) 2009-02-12 WO disclosed
CN-1199973-C Substituted carbolnie metal complex and application thereof SHANDONG SCIENCE & ENGINEERING (CN) 2005-05-04 CN disclosed
CN-1472212-A Substituted carbolnie metal complex and application thereof 山东理工大学 2004-02-04 CN disclosed
EP-1133473-B1 NEW MANUFACTURING PROCESS ASTRAZENECA AB (SE) 2003-04-09 EP disclosed
US-6350877-B1 MANUFACTURE OF CLEVIDIPINE BY SALT FORMATION ESTERIFICATION ASTRAZENECA AB (SE) 2002-02-26 US disclosed
EP-1133473-A1 NEW MANUFACTURING PROCESS AstraZeneca AB (SE) 2001-09-19 EP disclosed
WO-2000031035-A1 NEW MANUFACTURING PROCESS ASTRAZENECA AB (SE) 2000-06-02 WO disclosed
EP-0174816-A2 Biphenyl-based diester compounds and liquid crystal compositions containing same AJINOMOTO CO., INC. (JP) 1986-03-19 EP disclosed